Brian Skaug1, Shervin Assassi. 1. Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas Health Science Center Houston, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: To discuss recent advances in identification of biomarkers in systemic sclerosis for disease severity, prognosis, and treatment response. RECENT FINDINGS: Recent reports describe novel circulating markers of disease severity, autoantibody associations with specific manifestations including cancer, and skin gene expression-based predictors of modified Rodnan skin score progression and treatment response. Moreover, there is converging evidence that C-reactive protein and pneumoproteins such as Krebs von den Lungen-6 and chemokine ligand 18 could serve as prognostic biomarkers in systemic sclerosis-associated interstitial lung disease. SUMMARY: Several novel biomarkers show promise in improving the assessment of systemic sclerosis (SSc) disease severity, prognosis, and treatment response. Their potential utility in prospective selection of patients for clinical trials and in individual patient management require additional research.
PURPOSE OF REVIEW: To discuss recent advances in identification of biomarkers in systemic sclerosis for disease severity, prognosis, and treatment response. RECENT FINDINGS: Recent reports describe novel circulating markers of disease severity, autoantibody associations with specific manifestations including cancer, and skin gene expression-based predictors of modified Rodnan skin score progression and treatment response. Moreover, there is converging evidence that C-reactive protein and pneumoproteins such as Krebs von den Lungen-6 and chemokine ligand 18 could serve as prognostic biomarkers in systemic sclerosis-associated interstitial lung disease. SUMMARY: Several novel biomarkers show promise in improving the assessment of systemic sclerosis (SSc) diseaseseverity, prognosis, and treatment response. Their potential utility in prospective selection of patients for clinical trials and in individual patient management require additional research.
Authors: Katie Streicher; Sriram Sridhar; Mike Kuziora; Christopher A Morehouse; Brandon W Higgs; Yinong Sebastian; Christopher J Groves; Fernanda Pilataxi; Philip Z Brohawn; Ronald Herbst; Koustubh Ranade Journal: Arthritis Rheumatol Date: 2018-10-22 Impact factor: 10.995
Authors: Britta Maurer; Nicole Graf; Beat A Michel; Ulf Müller-Ladner; László Czirják; Christopher P Denton; Alan Tyndall; Carola Metzig; Vivian Lanius; Dinesh Khanna; Oliver Distler Journal: Ann Rheum Dis Date: 2014-06-30 Impact factor: 19.103
Authors: Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger Journal: Ann Rheum Dis Date: 2010-08-02 Impact factor: 19.103
Authors: Dinesh Khanna; Christopher P Denton; Angelika Jahreis; Jacob M van Laar; Tracy M Frech; Marina E Anderson; Murray Baron; Lorinda Chung; Gerhard Fierlbeck; Santhanam Lakshminarayanan; Yannick Allanore; Janet E Pope; Gabriela Riemekasten; Virginia Steen; Ulf Müller-Ladner; Robert Lafyatis; Giuseppina Stifano; Helen Spotswood; Haiyin Chen-Harris; Sebastian Dziadek; Alyssa Morimoto; Thierry Sornasse; Jeffrey Siegel; Daniel E Furst Journal: Lancet Date: 2016-05-05 Impact factor: 79.321
Authors: Anthony J Tyndall; Bettina Bannert; Madelon Vonk; Paolo Airò; Franco Cozzi; Patricia E Carreira; Dominique Farge Bancel; Yannick Allanore; Ulf Müller-Ladner; Oliver Distler; Florenzo Iannone; Raffaele Pellerito; Margarita Pileckyte; Irene Miniati; Lidia Ananieva; Alexandra Balbir Gurman; Nemanja Damjanov; Adelheid Mueller; Gabriele Valentini; Gabriela Riemekasten; Mohammed Tikly; Laura Hummers; Maria J S Henriques; Paola Caramaschi; Agneta Scheja; Blaz Rozman; Evelien Ton; Gábor Kumánovics; Bernard Coleiro; Eva Feierl; Gabriella Szucs; Carlos Alberto Von Mühlen; Valeria Riccieri; Srdan Novak; Carlo Chizzolini; Anna Kotulska; Christopher Denton; Paulo C Coelho; Ina Kötter; Ismail Simsek; Paloma García de la Pena Lefebvre; Eric Hachulla; James R Seibold; Simona Rednic; Jirí Stork; Jadranka Morovic-Vergles; Ulrich A Walker Journal: Ann Rheum Dis Date: 2010-06-15 Impact factor: 19.103
Authors: Dinesh Khanna; Daniel E Furst; Philip J Clements; Yannick Allanore; Murray Baron; Lazlo Czirjak; Oliver Distler; Ivan Foeldvari; Masataka Kuwana; Marco Matucci-Cerinic; Maureen Mayes; Thomas Medsger; Peter A Merkel; Janet E Pope; James R Seibold; Virginia Steen; Wendy Stevens; Christopher P Denton Journal: J Scleroderma Relat Disord Date: 2017 Jan-Apr
Authors: Jennifer M Franks; Viktor Martyanov; Guoshuai Cai; Yue Wang; Zhenghui Li; Tammara A Wood; Michael L Whitfield Journal: Arthritis Rheumatol Date: 2019-09-02 Impact factor: 15.483
Authors: Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin Journal: Arthritis Res Ther Date: 2021-03-06 Impact factor: 5.156
Authors: Victor Farutin; Elma Kurtagic; Joël R Pradines; Ishan Capila; Maureen D Mayes; Minghua Wu; Anthony M Manning; Shervin Assassi Journal: Arthritis Res Ther Date: 2021-10-15 Impact factor: 5.156